Craig Collard - Feb 22, 2023 Form 3 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Craig Collard
Stock symbol
HRTX
Transactions as of
Feb 22, 2023
Transactions value $
$0
Form type
3
Date filed
3/2/2023, 03:11 PM
Previous filing
Sep 27, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HRTX Common Stock 37.9K Feb 22, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HRTX Stock Option (Right to Buy) Feb 22, 2023 Common Stock 227K $2.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant (02/22/2023).
F2 The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (02/22/2023).